Dr. Ann Liebert

Dr Ann Liebert is a clinician/scientist at the Sydney Adventist Hospital and is Adjunct Senior Lecturer in the Faculty of Medicine, Sydney University. Ann’s current research is focussed on the molecular mechanisms of photobiomodulation and she is also currently implementing a number of clinical trials to assess the effectiveness of photobiomodulation as a preconditioning treatment for patients undergoing cardiac surgery, to treat Parkinson’s and Alzheimer’s diseases and to treat chronic headache. Clinical trials for treatment of Parkinson’s disease are currently being carried out in Adelaide and Sydney at the San Hospital (as chief coordinating investigator), funded by Parkinson’s South Australia and private donations. Laboratory investigations include experiments into the mechanisms of photobiomodulation at the cell membrane using erythrocytes and the effect of photobiomodulation on the microbiome humans and in a mouse model.

She has spoken at numerous international conferences on the topics of translational research and the proteomics of PBM. She currently is currently vice-president of the Australian Medical Photobiomodulation Association (AMPA), is a member of the Global Research Steering Committee for NAALT, is on the scientific advisory board of the WALT and is a session chair at SPIE Photonics West 2020 (Photobiomodulation Session).